In a groundbreaking development in the field of dietary health, Clasado Biosciences, in collaboration with the Primary Care Society for Gastroenterology (PCSG), has recently published a Real World Evidence (RWE) study. This study, led by Dr. Kevin Barrett and Dr. Marion Sloan, throws light on the substantial benefits of the prebiotic ingredient, Bimuno® GOS, particularly in addressing common gastrointestinal (GI) symptoms and sleep disturbances.
The findings of this study are pivotal for individuals suffering from Irritable Bowel Syndrome (IBS) and sleep issues. Participants in the study exhibited significant enhancements in their overall Quality of Life (QoL), indicating that Bimuno GOS can effectively improve both gastrointestinal health and sleep quality.
Dr. Lucien Harthoorn, R&D Director at Clasado, emphasizes the critical role of RWE studies in complementing clinical trial data. He notes that while clinical trials are conducted under controlled conditions, RWE studies offer valuable insights into the day-to-day effectiveness of products like Bimuno GOS. Harthoorn proudly states that Bimuno GOS is one of the most extensively researched prebiotic ingredients, and this study further solidifies its standing in the scientific community.
The study’s methodology included qualitative feedback from over 1,170 Bimuno users. This research is particularly relevant to health and nutrition formulators focused on developing gut health-supporting products. It confirms Bimuno GOS as a scientifically robust prebiotic ingredient choice.
Dr. Marion Sloan, Chair of the PCSG, points out the burgeoning research in the field of prebiotics. Prebiotics are non-digestible food components that can significantly alter gut microbiome composition, boosting beneficial gut bacteria. Sloan believes this RWE study is a valuable addition to the growing body of evidence on the positive effects of prebiotics on certain GI disorders and sleep quality.
The study’s results are published in the 16th issue of The Digest, a PCSG journal, and provide a promising outlook for the future of dietary interventions in managing gastrointestinal and sleep-related issues. For more information on PCSG and their ongoing research, visit their website at PCSG.
